Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. November 2016 08:00 ET | Quelle: Innocoll Holdings plc

Innocoll Holdings plc to Present at the Piper Jaffray Annual Healthcare Conference

ATHLONE, Ireland, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
15. November 2016 08:30 ET | Quelle: Innocoll Holdings plc

Innocoll to Report Third Quarter 2016 Financial Results and Host Webcast and Conference Call on November 22, 2016

ATHLONE, Ireland, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
14. November 2016 08:30 ET | Quelle: Innocoll Holdings plc

Innocoll Holdings plc to Present at the Stifel 2016 Healthcare Conference

ATHLONE, Ireland, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
03. November 2016 16:31 ET | Quelle: Innocoll Holdings plc

Innocoll Announces Top-Line Data From Phase 3 Trials With COGENZIA and NDA Submission for XARACOLL

COACT-1 and COACT-2 Phase 3 clinical trials for COGENZIA did not achieve statistical significance in improving clinical cure in diabetic foot infections (DFI)New Drug Application (NDA) for XARACOLL...
07. September 2016 16:01 ET | Quelle: Innocoll Holdings plc

Innocoll Holdings plc to Present at the Morgan Stanley Global Healthcare Conference

ATHLONE, Ireland, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
17. August 2016 08:00 ET | Quelle: Innocoll Holdings plc

Innocoll Holdings plc Announces Second Quarter 2016 Financial and Operating Results and Provides Corporate Update

ATHLONE, Ireland, Aug. 17, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
11. August 2016 16:01 ET | Quelle: Innocoll Holdings plc

Innocoll to Report Second Quarter 2016 Financial Results and Host Webcast and Conference Call on August 17, 2016

ATHLONE, Ireland, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
06. Juli 2016 09:00 ET | Quelle: Innocoll Holdings plc

Innocoll Holdings plc to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference

ATHLONE, Ireland, July 06, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
23. Juni 2016 09:00 ET | Quelle: Innocoll Holdings plc

Innocoll Holdings plc Announces the Completion of Enrollment in Two Pivotal Phase 3 Clinical Trials of COGENZIA for the Treatment of Diabetic Foot Infections

ATHLONE, Ireland, June 23, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
16. Juni 2016 09:20 ET | Quelle: Innocoll Holdings plc

Innocoll Holdings plc to Present at the JMP Securities Life Sciences Conference

ATHLONE, Ireland, June 16, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...

Nächste Seite